From: Treatment outcomes of acute postoperative infectious endophthalmitis
N (%)/Mean (SD) | Final vision (LogMAR) | P | |
---|---|---|---|
Age, years | 67.65(9.52) | 0.374a | |
Eye(OD) | 29 (35.4) | 0.816b | |
Gender (M) | 46 (56.1) | 0.924b | |
Systemic disease | |||
Diabetes | 30 (36.60) | 0.54 (0.64) / 1.03 (0.96) | 0.019b* |
Hypertension | 38 (46.30) | 0.412b | |
Heart disease | 10 (12.20) | 0.603b | |
Hemodialysis | 4 (4.90) | 0.66 (0.75) / 1.80 (1.00) | 0.004b* |
Liver disease | 3 (3.70) | 0.836b | |
Duration, days | 3.26 (3.71) | 0.631a | |
Interval, days | 2.30 (2.08) | 0.888a | |
Symptoms | |||
Blur | 67 (81.70) | 0.669b | |
Pain | 48 (58.50) | 0.366b | |
Baseline vision | 1.92 (0.54) | 0.030a* | |
Baseline IOP, mmHg | 16.00 (7.62) | 0.051a | |
Surgery before endophthalmitis | |||
cataract | 66 (80.49) | 0.57 (0.68) | 0.001c* |
VT | 12 (14.63) | 1.38 (1.07) | |
Intravitreal injection | 4 (4.88) | 0.97 (0.74) | |
Signs | |||
Hypopyon | 67 (81.70) | 0.844b | |
Vitritis(mild to moderate / severe) | 8 (8.5) / 75 (91.50) | 0.12 (0.11) / 0.76 (0.81) | < 0.001b* |
Treatment of endophthalmitis | |||
Pre-VT IVI antibiotics | 43 (52.4) | 0.740b | |
VT combined IVI antibiotics VT with 23 G/20 G | 71 (86.60) 46 (50.1)/34 (34.14) | 0.78 (0.84) 0.77 (0.85)/0.62 (0.79) | < 0.001b* 0.395 b |
Post-VT IVI antibiotics | 51 (62.20) | 0.230b | |
IVI antibiotics without VT | 11 (13.40) | 0.28 (0.16) | < 0.001b* |
IVI antibiotics amount | 2.59 (1.23) | 0.014a* | |
Culture positive | 30 (36.60) | 0.076b | |
Complications | 18 (22.00) | 0.5 (0.63) / 1.44 (0.89) | < 0.001b* |
Retinal detachment | 8 (9.75) | 0.65 (0.75) / 1.19 (1.08) | 0.214b |
Final vision | 0.71 (0.80) | < 0.001d* | |
Follow-up time | 14.40 (18.99) | 0.945a |